Trials / Unknown
UnknownNCT01375465
The 001-DIOR Multicenter Registry
The 001-DIOR Multicenter Registry (A Novel Percutaneous Coronary Intervention With the New Paclitaxel-eluting Balloon DIOR in Ostial Bifurcated Lesions)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Eurocor GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The 001 DIOR study is a prospective, multicenter registry of percutaneous coronary intervention (PCI) to assess the clinical success, efficacy and safety of the Paclitaxel-eluting balloon DIOR (Eurocor GmbH, Germany) for the treatment of de novo ostial bifurcated lesions (001 of Medina classification). The DIOR balloon will be used to treat the stenotic site branch.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DIOR drug-eluting PTCA balloon | Treatment for 45 seconds with the DIOR balloon (3 µg/mm2 Paclitaxel concentration on balloon surface) |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2013-07-01
- First posted
- 2011-06-17
- Last updated
- 2013-09-23
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01375465. Inclusion in this directory is not an endorsement.